Tools & Resources / Treatment Tools

Ideas to
help you manage your 

Loren, Actual FEIBA Patient

These handy tools can help you set goals, find insurance information and identify resources that may help cover costs.

Set your goals.

This simple worksheet helps you work with your healthcare provider to create realistic goals and a plan to reach them.

Goals worksheet

Keep an infusion log.

Streamline your infusion log and vial records into one document.

Infusion log

Do the 5!

Check out these tips from the National Prevention Program, a collaboration between the NHF, Centers for Disease Control and Prevention, HTCs, and members of the bleeding conditions community.23

They may help you prevent or reduce the complications of hemophilia:

  1. Get a comprehensive checkup every year
  2. Get vaccinated (and keep your vaccinations up to date)
  3. Treat bleeds early and adequately
  4. Protect your joints by exercising regularly and maintaining a healthy weight
  5. Get tested regularly for blood-borne infections

Always talk with your doctor for advice and guidance on health matters.


Shire’s Hematology website is filled with helpful information, including articles, videos, tools, and links to resources ranging from community and educational programs to financial assistance options. Shire support programs are available to all patients, regardless of treatment.

Learn more

Locate an HTC.

Hemophilia Treatment Centers, or HTCs, are specialized healthcare centers staffed by health professionals experienced in treating hemophilia. They're located coast to coast.

Find an HTC

Understand your options.

Insurance is complicated. Luckily, Shire has launched a site that simplifies the info and offers tools to help patients and caregivers like you find treatment coverage.

Explore the site

Find a rep.

Your local Shire rep is ready to meet with you one-on-one to offer encouragement, information, and a world of support on topics from taking FEIBA to obtaining information on medication costs.

Find your rep

Want to find other types of support? Check out our Community section.

FEIBA [Anti-Inhibitor Coagulant Complex]
Indications and Detailed Important Risk Information for Patients

INDICATIONS FOR FEIBA [Anti-Inhibitor Coagulant Complex]

FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Use around the time of surgery
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

FEIBA is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor VIII or coagulant factor IX.

  • Blood clots that block blood vessels and their effects have been reported during post-marketing surveillance following infusion of FEIBA, particularly following administration of high doses and/or in patients with a risk of forming blood clots.
  • If you experience any of these side effects, call your doctor right away.

You should not use FEIBA if:

  • You had a previous severe allergic reaction to the product (reactions causing discomforts that are damaging and life threatening)
  • You have signs of development of small blood vessel clots throughout the body
  • You have sudden blood vessel clots or blocked blood vessels, (e.g., heart attack or stroke)

Events involving blood clots blocking blood vessels can occur with FEIBA, particularly after receiving high doses and/or in patients with risk factors for clotting.

Infusion of FEIBA should not exceed a dose of 100 units per kg body weight every 6 hours and daily doses of 200 units per kg of body weight. Maximum injection or infusion rate must not exceed 2 units per kg of body weight per minute.

At first sign or symptom of a sudden blood vessel clot or blocked blood vessel (e.g., chest pain or pressure, shortness of breath, altered consciousness, vision, or speech, limb or abdomen swelling and/or pain), stop FEIBA administration promptly and seek emergency medical treatment.

Allergic-type hypersensitivity reactions, including severe, sometimes fatal allergic reactions that can involve the whole body, can occur following the infusion of FEIBA. Call your doctor or get emergency treatment right away if you get a rash, hives or welts, experience itching, tightness of the throat, vomiting, abdominal pain, chest pain or tightness, difficulty breathing, lightheadedness, dizziness, nausea or fainting.

Because FEIBA is made from human plasma it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) agent and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

The most frequent side effects observed during the prophylaxis trial were anemia, diarrhea, bleeding into a joint, signs of hepatitis B surface antibodies, nausea, and vomiting.

The serious side effects seen with FEIBA are allergic reactions and clotting events involving blockage of blood vessels, which include stroke, blockage of the main blood vessel to the lung, and deep vein blood clots.

Call your doctor right away about any side effects that bother you during or after you stop taking FEIBA.

Please see FEIBA full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.